Home/Filings/4/0001171000-16-000122
4//SEC Filing

Nexvet Biopharma plc 4

Accession 0001171000-16-000122

CIK 0001618561operating

Filed

Apr 3, 8:00 PM ET

Accepted

Apr 4, 7:12 PM ET

Size

7.2 KB

Accession

0001171000-16-000122

Insider Transaction Report

Form 4
Period: 2016-03-31
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2016-03-31$0.13/sh+500$6312,900 total
  • Exercise/Conversion

    Restricted Share Units

    2016-03-315004,000 total
    Exercise: $0.13From: 2016-03-31Exp: 2019-07-01Ordinary Shares (500 underlying)
Footnotes (1)
  • [F1]500 of the Restricted Share Units vested and became convertible on 3/31/16, and 500 Restricted Share Units shall vest and become convertible on each of 6/30/16, 9/30/16, 12/31/16, 3/31/17, 6/30/17, 9/30/17, 12/31/17 and 3/31/18 in each case subject to payment of the nominal value per share to Issuer within 30 days of vesting.

Issuer

Nexvet Biopharma plc

CIK 0001618561

Entity typeoperating
IncorporatedIreland

Related Parties

1
  • filerCIK 0001618561

Filing Metadata

Form type
4
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 7:12 PM ET
Size
7.2 KB